• 1
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. American Psychiatric Association, Washington, DC, 2000.
  • 2
    Kawakami N, Takeshima T, Ono Y et al. Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002–2003. Psychiatry Clin. Neurosci. 2005; 59: 441452.
  • 3
    Maeda F, Nathan JH. Understanding taijin kyofusho through its treatment, Morita therapy. J. Psychosom. Res. 1999; 46: 525530.
  • 4
    Kasahara Y, Fujinawa A, Sekiguchi H, Matsumoto M. Fear of Eye-to-Eye Confrontation and Fear of Emitting Bad Odors (in Japanese). Igaku Shoin, Tokyo, 1972.
  • 5
    Yamashita I. Taijin-Kyofu (in Japanese). Kanahara, Tokyo, 1977.
  • 6
    Nagata T, Oshima J, Wada A, Yamada H, Iketani T, Kiriike N. Open trial of milnacipran for Taijin Kyofusho in Japanese patients with social anxiety disorder. Int. J. Psych. Clin. Pract. 2003; 7: 107112.
  • 7
    Nagata T, van Vliet I, Yamada H, Kataoka K, Iketani T, Kiriike N. An open trial of paroxetine for the ‘offensive subtype’ of taijin kyofusho and social anxiety disorder. Depress. Anxiety 2006; 23: 168174.
  • 8
    Takahashi T. Social phobia syndrome in Japan. Compr. Psychiatry 1989; 30: 4552.
  • 9
    Kleinknecht RA, Dinnel DL, Kleinknecht EE, Hiruma N, Harada N. Cultural factors in social anxiety: a comparison of social phobia symptoms and Taijin kyofusho. J. Anxiety Disord. 1997; 11: 157177.
  • 10
    Choy Y, Schneier FR, Heimberg RG, Oh KS, Liebowitz MR. Features of the offensive subtype of Taijin-Kyofu-Sho in US and Korean patients with DSM-IV social anxiety disorder. Depress. Anxiety 2008; 25: 230240.
  • 11
    Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005; 62: 617627.
  • 12
    Kessler RC, Angermeyer M, Anthony JC et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007; 6: 168176.
  • 13
    Gunstad J, Phillips KA. Axis I comorbidity in body dysmorphic disorder. Compr. Psychiatry 2003; 44: 270276.
  • 14
    Stein MB, Hazen AL. Modified Version of Structured Clinical Interview for DSM-IV (SCID-P). Anxiety Disorders Research Program, University of California, San Diego, San Diego, CA, 1995.
  • 15
    Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM-III-R – Patient Edition (SCID-P, Version 1.0). American Psychiatric Press, Washington, DC, 1990.
  • 16
    Takahashi S, Hanada K, Ono Y. Japanese Version of SCID DSM-III-R. Igaku-shoin, Tokyo, 1992.
  • 17
    Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM-III-R – Personality Disorders (SCID-II, Version 1.0). American Psychiatric Press, Washington, DC, 1990.
  • 18
    First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders, SCID-II. American Psychiatric Press, Washington, DC, 1997.
  • 19
    Takahashi S, Ohsone A. Japanese Version of SCID-II (Structured Clinical Interview for DSM-IV Axis II Personality Disorders). Igaku-Shoin, Tokyo, 2002.
  • 20
    Liebowitz MR. Social phobia. Mod. Probl. Pharmacopsychiatry 1987; 22: 141173.
  • 21
    Nagata T, Kaye WH, Kiriike N, Rao R, McConaha C, Plotnicov KH. Physical and sexual abuse histories in patients with eating disorders: a comparison of Japanese and American patients. Psychiatry Clin. Neurosci. 2001; 55: 333340.
  • 22
    Wenzel A, Holt CS. Social phobia and its relationship to clinical syndromes in adulthood. In : Hofman SG, DiBartolo PM (eds). From Social Anxiety to Social Phobia: Multiple Perspective. Allyn and Bacon, Boston, MA, 2001; 130147.
  • 23
    Felm L, Wittchen HU. Comorbidity of social anxiety disorder. In : Bandelow B, Stein DJ (eds). Social Anxiety Disorder. Marcel Dekker, New York, 2004; 4963.
  • 24
    Dingemans AE, van Vliet IM, Couvee J, Westenberg HG. Characteristics of patients with social phobia and their treatment in specialized clinics for anxiety disorders in the Netherlands. J. Affect. Disord. 2001; 65: 123129.
  • 25
    Demyttenaere K, Bruffaerts R, Posada-Villa J et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 25812590.
  • 26
    Schneier FR, Blanco C, Antia SX, Liebowitz MR. The social anxiety spectrum. Psychiatr. Clin. North Am. 2002; 25: 757774.
  • 27
    Reichborn-Kjennerud T, Czajkowski N, Neale MC et al. Genetic and environmental influences on dimensional representations of DSM-IV cluster C personality disorders: a population-based multivariate twin study. Psychol. Med. 2007; 37: 645653.
  • 28
    Pfohl B, Blum N. Obsessive-compulsive personality disorder. In : Livesley WJ (ed.). The DSM-IV Personality Disorders. Guilford Press, New York, 1995; 261283.
  • 29
    Hummelen B, Wilberg T, Pedersen G, Karterud S. The quality of the DSM-IV obsessive-compulsive personality disorder construct as a prototype category. J. Nerv. Ment. Dis. 2008; 196: 446455.
  • 30
    Chavira DA, Stein MB. Childhood social anxiety disorder: from understanding to treatment. Child Adolesc. Psychiatr. Clin. N. Am. 2005; 14: 797818.
  • 31
    Stein MB, Gelernter J, Smoller JW. Genetic aspects of social anxiety and related traits. In : Bandelow B, Stein DJ (eds). Social Anxiety Disorder: More Than Shyness. Marcel Dekker, New York, 2004; 197214.
  • 32
    Kim J, Rapee RM, Gaston JE. Symptoms of offensive type Taijin-Kyofusho among Australian social phobics. Depress. Anxiety 2008; 25: 601608.